Información del artículo
El Texto completo está disponible en PDF
References
[1.]
G. Reimondo, S. Bovio, B. Allasino, M. Terzolo, A. Angeli.
Secondary hypoadrenalism.
Pituitary, 11 (2008), pp. 147-154
[2.]
C.H. Polman, S.C. Reingold, G. Edan, M. Filippi, H.P. Hartung, L. Kappos, et al.
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald” criteria.
Ann Neurol, 58 (2005), pp. 840-846
[3.]
M. Andrioli, F. Pecori Giraldi, F. Cavagnini.
Isolated corticotrophin deficiency.
Pituitary, 9 (2006), pp. 289-295
[4.]
D. Mason, I. MacPhee, F. Antoni.
The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat.
Immunology, 70 (1990), pp. 1-5
[5.]
Z.A. Erkut, M.A. Hofman, R. Radid, D.F. Swaab.
Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis.
J Neuroinmmunol, 62 (1995), pp. 27-33
[6.]
F. Then Bergh, T. Kümpfel, C. Trenkwalder, R. Rupprecht, F. Holsboer.
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.
Neurology, 53 (1999), pp. 772-777
[7.]
I. Huitinga, C.J.A. De Groot, P. Van der Valk, W. Kampherst, F.J. Tilders, D.F. Swaab.
Hypothalamic lesions in multiple sclerosis.
J Neuropathol Exp Neurol, 60 (2001), pp. 1208-1218
[8.]
I. Huitinga, Z. Erkut, D. van Beurden, F. Swaab.
Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions.
Ann Neurol, 55 (2004), pp. 37-45
[9.]
A. Moya Chimenti, R. Álvarez Doforno, Á. Villaroel Bajo, R. Frutos, L.F. Pallardo Sánchez, C. Álvarez Escolá.
Anticuerpos antihipófisis en pacientes con sospecha de hipofisitis autoinmune.
Endocrinol Nutr, 57 (2010), pp. 160-164
[10.]
S.M. Gold, A. Raji, I. Huitinga, K. Wiedemann, K.H. Schulz, Ch. Heesen.
Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.
J Neuroimmunol, 165 (2005), pp. 186-191
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición
